back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-03 14:38 Tx date 2025-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2025-03-20 12:47 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-250,000 vol |
750,000 | |
| Filed 2025-03-20 12:46 Tx date 2024-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-20 12:46 Tx date 2025-03-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Holder: Avery Professional Corporation (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+250,000 vol |
250,000 | |
| Filed 2025-03-20 12:45 Tx date 2024-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Holder: Avery Professional Corporation (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-12-17 15:51 Tx date 2024-12-13 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,000,000 vol |
1,000,000 | |
| Filed 2024-12-17 15:50 Tx date 2024-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Avery, William Edward Keith
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|